Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,837 | 152 | 97.3% |
| Education | $53.23 | 4 | 1.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $25.00 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $461.69 | 20 | $0 (2024) |
| Lilly USA, LLC | $224.28 | 13 | $0 (2024) |
| Amgen Inc. | $224.24 | 10 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $212.81 | 9 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $199.44 | 15 | $0 (2019) |
| Novo Nordisk Inc | $189.33 | 10 | $0 (2024) |
| PFIZER INC. | $184.41 | 10 | $0 (2024) |
| Allergan Inc. | $155.57 | 8 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $113.91 | 12 | $0 (2023) |
| Shire North American Group Inc | $106.46 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $358.37 | 16 | AstraZeneca Pharmaceuticals LP ($48.24) |
| 2023 | $157.04 | 7 | Bayer Healthcare Pharmaceuticals Inc. ($39.92) |
| 2022 | $44.62 | 2 | Lilly USA, LLC ($27.17) |
| 2020 | $161.90 | 9 | Lilly USA, LLC ($30.97) |
| 2019 | $690.17 | 36 | AstraZeneca Pharmaceuticals LP ($112.92) |
| 2018 | $827.58 | 48 | AstraZeneca Pharmaceuticals LP ($161.29) |
| 2017 | $675.93 | 39 | AstraZeneca Pharmaceuticals LP ($139.24) |
All Payment Transactions
157 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $31.46 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/27/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: DIABETES | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Obesity | ||||||
| 07/24/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $27.96 | General |
| Category: Cardio-renal | ||||||
| 06/21/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: NEUROSCIENCE | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Gastroenterology | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
| 04/02/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Respiratory | ||||||
| 02/09/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: PAIN | ||||||
| 01/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Inflammation | ||||||
| 01/12/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Endocrinology | ||||||
| 11/08/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: Cardio-renal | ||||||
| 10/06/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: NEUROSCIENCE | ||||||
| 09/12/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $26.31 | General |
| Category: Cardio-renal | ||||||
| 04/17/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $34.46 | General |
| Category: NEUROSCIENCE | ||||||
| 02/07/2023 | Lilly USA, LLC | LYUMJEV (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Diabetes | ||||||
| 01/10/2023 | Hologic Sales and Service, LLC | APTIMA (Device), THINPREP 2000 PROCESSOR | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diagnostics | ||||||
| 09/27/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Cardio-renal | ||||||
| 08/11/2022 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $27.17 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,358 | 1,923 | $273,805 | $139,130 |
| 2022 | 24 | 1,304 | 3,257 | $292,377 | $138,432 |
| 2021 | 26 | 2,360 | 4,297 | $317,496 | $157,990 |
| 2020 | 20 | 1,260 | 3,040 | $265,011 | $118,915 |
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 251 | 480 | $106,560 | $40,784 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 304 | 304 | $48,032 | $39,043 | 81.3% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 302 | 306 | $29,070 | $24,081 | 82.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 197 | 257 | $41,891 | $14,063 | 33.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 30 | $8,790 | $3,898 | 44.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $3,486 | $3,172 | 91.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 13 | 14 | $3,990 | $3,079 | 77.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 15 | 15 | $3,150 | $2,463 | 78.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $2,310 | $1,803 | 78.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 11 | 78 | $5,616 | $1,215 | 21.6% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 23 | 23 | $2,185 | $1,131 | 51.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 134 | $7,236 | $1,103 | 15.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 17 | 24 | $3,192 | $1,077 | 33.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 20 | $2,140 | $809.64 | 37.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 44 | $2,728 | $458.32 | 16.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 16 | 78 | $1,482 | $358.62 | 24.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $308.00 | $301.84 | 98.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 41 | 45 | $765.00 | $99.00 | 12.9% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 12 | 12 | $96.00 | $73.32 | 76.4% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 12 | 12 | $96.00 | $60.96 | 63.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $682.00 | $57.45 | 8.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 240 | 435 | $96,570 | $33,948 | 35.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 223 | 223 | $35,234 | $28,995 | 82.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 284 | 439 | $71,557 | $24,805 | 34.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 1,260 | $25,200 | $18,963 | 75.3% |
About Dr. Brad Andersen, MD
Dr. Brad Andersen, MD is a Family Medicine healthcare provider based in Poulsbo, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1598831406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brad Andersen, MD has received a total of $2,916 in payments from pharmaceutical and medical device companies, with $358.37 received in 2024. These payments were reported across 157 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,837).
As a Medicare-enrolled provider, Andersen has provided services to 6,282 Medicare beneficiaries, totaling 12,517 services with total Medicare billing of $554,467. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Poulsbo, WA
- Active Since 11/24/2006
- Last Updated 05/23/2011
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1598831406
Products in Payments
- FARXIGA (Drug) $277.82
- TRULICITY (Drug) $148.08
- VRAYLAR (Drug) $145.29
- STIOLTO RESPIMAT (Drug) $101.03
- Ozempic (Drug) $89.89
- CHANTIX (Drug) $86.53
- Kerendia (Drug) $85.33
- Trintellix (Drug) $83.79
- SYMBICORT (Drug) $83.75
- Prolia (Biological) $80.63
- Aimovig (Biological) $75.14
- JANUVIA (Drug) $65.49
- JARDIANCE (Drug) $63.13
- XIFAXAN (Drug) $60.62
- TOUJEO (Drug) $58.36
- MYDAYIS (Drug) $55.82
- QULIPTA (Drug) $53.12
- STIOLTO (Drug) $48.65
- BREZTRI (Drug) $48.24
- Otezla (Drug) $43.96
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Poulsbo
Matthew Johnson, Md, MD
Family Medicine — Payments: $3,103
Dr. Charles Power, Md, MD
Family Medicine — Payments: $2,977
Dr. Mark Hoffman, Md, MD
Family Medicine — Payments: $2,551
Sally Fleischman, M.d, M.D
Family Medicine — Payments: $2,450
Robert Callahan, D.o, D.O
Family Medicine — Payments: $1,159
Ms. Teresa Andersen, Md, MD
Family Medicine — Payments: $1,122